The EuroCC-2 team met with Dr Andreas Artopoulos, Director of EXMACHINA 3D Medical Modelling in dental and craniomaxillofacial surgery with 3d visualisation.
The meeting involved introductions and presentations of the main activities of EuroCC-2 and EXMACHINA, focusing on synergies on the use of Computer Vision for image analysis and reconstruction.
The EuroCC-2 team met with C.I.P. Citizens In Power (CIP), an independent non-profit, non-governmental organization, located in Nicosia, focusing on the fields of global education, social innovation, entrepreneurship, STEM and sustainable growth.
The meeting with CIP’s Founder and Director Angelos Parmatzias, and Co-Founder, Head of R&D Giota Mourettou, involved introductions and presentations of the main activities of EuroCC-2 and CIP, focusing on the use of AI and data analytics to tackle social problems of refugees, the elderly and education.
EuroCC-2 looks forward to a productive collaboration with CIP!
The EuroCC-2 team met with Mr Sofocles Vlassides, owner of Vlassides Winery, an award winning winery located in Koilani (Limassol mountainous district) that utilises innovative approaches and focuses in sustainable development. The winery has a capacity to produce 110,000 bottles annually and has won several awards from year 2000 an onwards.
The meeting involved introductions and presentations of the main activities of EuroCC-2 and Vlassides winery, focusing on the use of data analytics for disease monitoring and management.
EuroCC-2 looks forward to a productive collaboration with Vlassides Winery!
The EuroCC-2 team met with Dr Haris Zacharatos, CEO of Cellock, a software development company specialising in custom Software Development, Hardware Development, Data Analytics and Artificial Intelligence solutions, Support Management, and more.
The meeting involved introductions and presentations of the main activities of EuroCC-2 and Cellock, and identifying many synergies on the use of HPC, High Performance data analytics and the latest AI developments in the software development.
November 2023
July 2023
The EuroCC-2 team met with Ask Wire, a fintech company specializing in real estate intelligence, real estate profiles and spatial analytics for the financial sector. The meeting involved brief introductions on the main activities of EuroCC-2 and Ask Wire, with the discussion focusing on ways through which EuroCC-2 can help Ask Wire enhance their data analytics platform using the latest AI developments.
EuroCC-2 looks forward to a productive collaboration with Ask Wire!
June 2023
The EuroCC-2 team recently met with the founders of Appteum, Giannis Dimitriou and Nikolas Theodorou. Appteum is a developer tools startup, which has created a cloud platform for backend developers, focusing on speed, security and efficiency.
The meeting involved a very informative and productive discussion, with EuroCC-2 members offering consultation on how Appteum can enhance its platform with new features, relying on the latest AI developments.
The EuroCC-2 team had a very informative meeting with MoodHood, a company specializing on video conferencing software for educational purposes. MoodHood presented their latest developments on educational video conferencing tools, including enhanced features for both the teachers and the students, relying on AI methodologies.
The presentation was followed by a fruitful discussion, with EuroCC-2 members providing feedback on the conferencing tool and ideas on how it can be improved to enhance the educational experience.
We recently met with a group of clinicians and medical physicists from the German Oncology Center (GOC), at The Cyprus Institute premises. GOC is an advanced medical center, with state-of-the-art equipment and facilities. GOC has been at the forefront of research, seeking novel treatment strategies and new ways for improving the patients’ quality of life.
During this very productive meeting, we discussed ways in which EuroCC-2 can help GOC deal with current clinical problems and improve the patient experience, through the use of advanced data-driven technologies.
We look forward to a fruitful collaboration with the German Oncology Center!